JP2022089821A5 - - Google Patents

Download PDF

Info

Publication number
JP2022089821A5
JP2022089821A5 JP2022042101A JP2022042101A JP2022089821A5 JP 2022089821 A5 JP2022089821 A5 JP 2022089821A5 JP 2022042101 A JP2022042101 A JP 2022042101A JP 2022042101 A JP2022042101 A JP 2022042101A JP 2022089821 A5 JP2022089821 A5 JP 2022089821A5
Authority
JP
Japan
Prior art keywords
urolithin
seq
polynucleotide
following
ellagic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022042101A
Other languages
English (en)
Japanese (ja)
Other versions
JP7473573B2 (ja
JP2022089821A (ja
Filing date
Publication date
Priority claimed from JP2018010860A external-priority patent/JP7044574B2/ja
Application filed filed Critical
Priority to JP2022042101A priority Critical patent/JP7473573B2/ja
Publication of JP2022089821A publication Critical patent/JP2022089821A/ja
Publication of JP2022089821A5 publication Critical patent/JP2022089821A5/ja
Application granted granted Critical
Publication of JP7473573B2 publication Critical patent/JP7473573B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022042101A 2018-01-25 2022-03-17 新規ラクトナーゼ Active JP7473573B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022042101A JP7473573B2 (ja) 2018-01-25 2022-03-17 新規ラクトナーゼ

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018010860A JP7044574B2 (ja) 2018-01-25 2018-01-25 新規ラクトナーゼ
JP2022042101A JP7473573B2 (ja) 2018-01-25 2022-03-17 新規ラクトナーゼ

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018010860A Division JP7044574B2 (ja) 2018-01-25 2018-01-25 新規ラクトナーゼ

Publications (3)

Publication Number Publication Date
JP2022089821A JP2022089821A (ja) 2022-06-16
JP2022089821A5 true JP2022089821A5 (cg-RX-API-DMAC7.html) 2022-11-21
JP7473573B2 JP7473573B2 (ja) 2024-04-23

Family

ID=67470880

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018010860A Active JP7044574B2 (ja) 2018-01-25 2018-01-25 新規ラクトナーゼ
JP2022042101A Active JP7473573B2 (ja) 2018-01-25 2022-03-17 新規ラクトナーゼ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018010860A Active JP7044574B2 (ja) 2018-01-25 2018-01-25 新規ラクトナーゼ

Country Status (1)

Country Link
JP (2) JP7044574B2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4006163A4 (en) * 2019-07-25 2024-01-03 Daicel Corporation ENZYME FOR DEHYDROXYLATION OF THE HYDROXYL GROUP IN A UROLITHIN COMPOUND

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2510216B1 (es) * 2013-03-20 2015-10-27 Consejo Superior De Investigaciones Científicas (Csic) Microorganismo capaz de convertir ácido elágico y elagitaninos en urolitinas y uso del mismo
JP6760685B2 (ja) * 2016-04-19 2020-09-23 株式会社ダイセル ウロリチン類の製造方法

Similar Documents

Publication Publication Date Title
JP2022514743A5 (cg-RX-API-DMAC7.html)
JP2005512545A5 (cg-RX-API-DMAC7.html)
JP2005512535A5 (cg-RX-API-DMAC7.html)
JP2005512537A5 (cg-RX-API-DMAC7.html)
JP2005512534A5 (cg-RX-API-DMAC7.html)
JP2005512536A5 (cg-RX-API-DMAC7.html)
WO2015007033A1 (zh) 一种热稳定性改良的木聚糖酶XynAS9-m突变体及其基因和应用
CN106367408A (zh) Pet分解酶突变体、编码基因及其应用
CN113862233A (zh) 提高葡萄糖氧化酶的酸稳定性的方法及突变体q241e/r499e、基因和应用
CN110628742A (zh) 转氨酶突变体及其应用
CN113151211A (zh) 一种α-1,3-岩藻糖基转移酶突变体及利用该突变体制备3-岩藻糖基乳糖的应用
JP2022089821A5 (cg-RX-API-DMAC7.html)
JP2023521772A5 (cg-RX-API-DMAC7.html)
CN117230051B (zh) 一种褐藻胶裂解酶突变体Pl7MaM及其制备方法与应用
CN107460176B (zh) 一种过氧化物酶DyP35基因及其表达蛋白和应用
CN105886484A (zh) 一种嗜热纤维素酶及其编码基因和应用
CN108841851B (zh) 一种利用食源安全性宿主表达谷氨酰胺转氨酶的方法
JP2023544408A5 (cg-RX-API-DMAC7.html)
JP2023521972A5 (cg-RX-API-DMAC7.html)
CN118460490A (zh) 一种高底物选择性的核糖醇脱氢酶突变体及其应用
JP2003512046A5 (cg-RX-API-DMAC7.html)
IL305924A (en) Cyclic GMP-AMP synthase (CGAS) variant transgenic enzymes
CN118792288B (zh) 一种pH稳定性高的精氨酸脱亚胺酶突变体及其在肿瘤治疗中的应用
CN119614527B (zh) Gdp-岩藻糖合成酶多肽及其应用
JPWO2020213604A5 (cg-RX-API-DMAC7.html)